ANZEMET (Validus Pharmaceuticals LLC)


Welcome to the PulseAid listing for the ANZEMET drug offered from Validus Pharmaceuticals LLC. This Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Validus Pharmaceuticals LLC
NON-PROPRIETARY NAME: dolasetron mesylate
SUBSTANCE NAME: DOLASETRON MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1997-09-11
END MARKETING DATE: 0000-00-00


ANZEMET HUMAN PRESCRIPTION DRUG Details:

Item DescriptionANZEMET from Validus Pharmaceuticals LLC
LABELER NAME: Validus Pharmaceuticals LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/1)
START MARKETING DATE: 1997-09-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 30698-120_290c93ea-741e-4fe8-bf2a-7da24ee1aa87
PRODUCT NDC: 30698-120
APPLICATION NUMBER: NDA020623

Other DOLASETRON MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalANZEMET
sanofi-aventis U.S. LLCAnzemet
Validus Pharmaceuticals LLCANZEMET